Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845013 · ClinicalTrials.gov registry record
Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 365
- Enrollment target
NCT00845013 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 365 participants.
The verdict
NCT00845013 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 365 participants
- Enrollment target
Study Summary
The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospective observational cohort study to determine the association between highly active antiretroviral therapy (HAART) and viral suppression in HIV-infected patients who have been identified to have pre-clinical pulmonary hypertension (Aim 1). In addition, we will investigate the mechanistic role of the HIV-1 Nef protein and HHV-8 infection in the development and progression of pulmonary hypertension in individuals with HIV (Aim 2). We will also investigate endothelial function in HIV-infected patients with pulmonary hypertension (Aim 3).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2007-11 |
| Est. Completion | 2021-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00845013
The ClinicalTrials.gov registry entry for NCT00845013 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00845013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00845013 about?
NCT00845013 is a clinical study titled "Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension". The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospective observational cohort study to determine the association between highly active antiretroviral therapy (HAART) ...
What is the current status of trial NCT00845013?
This trial is currently completed. The enrollment target is 365 participants. The study started on 2007-11. Estimated completion is 2021-01.
Who is sponsoring clinical trial NCT00845013?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.